EAST END GROUP, LLC

Lobbying for LONGHORN · Vaccine and diagnostic development and manufacturing.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Reauthorization of the Pandemic and All-Hazards Preparedness Act, legislative and regulatory issues related to vaccine and diagnostic research, development and stockpiling. LHHS preparedness appropriations.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.